Lithium Orotate

There is a mineral that has been quietly disappearing from our food and water supply for decades, and in regions where it’s still present in the soil and water, depression rates are lower, suicide rates are lower, and psychiatric hospital admissions are fewer. The data on this is remarkably consistent across dozens of countries and over 100 million people.

That mineral is lithium. And before you stop reading, this is not a discussion about psychiatric medication versions of lithium, but lithium orotate the trace mineral.

Most people hear the word lithium and immediately picture a heavy-duty drug prescribed for bipolar disorder, something with a narrow therapeutic window, regular blood monitoring, and a long list of potential side effects.

That association is understandable, and it’s also the single biggest reason this nutrient is so widely overlooked. The pharmaceutical form and the nutritional form are not the same thing. The dose makes all the difference.

At nutritional doses, lithium behaves more like a trace mineral than a drug. It supports mood stability, sleep quality, stress resilience, and long-term brain health. There is a growing body of research suggesting it may belong in the same category as iodine or zinc: a nutrient we require in small amounts, which is increasingly absent from modern diets.

This article covers what lithium orotate is, why the form matters, what the evidence shows, who should not take it, and how to approach dosing lithium orotate. 

Key Takeaways

• Lithium orotate is not the same as pharmaceutical lithium. Prescription lithium carbonate is used at 600–1800 mg/day with blood monitoring; lithium orotate supplements typically deliver 5 mg of elemental lithium, which is a nutritional trace mineral dose.
• The water data is striking. A 2021 meta-analysis of 113 million people across 2,678 regions found that higher lithium concentrations in drinking water were consistently associated with lower suicide rates and fewer psychiatric hospital admissions.
• Low lithium may impair B12 function. Lithium plays a role in transporting B12 into cells; without it, B12 can look normal on blood tests while failing to do its job inside the cell.
• The neuroprotective evidence. Low-dose lithium inhibits GSK-3 beta (an enzyme implicated in Alzheimer’s pathology) and increases BDNF, the brain’s primary growth and repair factor.
• Not everyone should take it. People with kidney disease, those on prescription lithium, and those using NSAIDs, ACE inhibitors, or diuretics need to approach this carefully or avoid it entirely.

What Is Lithium Orotate?

Lithium is a naturally occurring element found in soil, rock, and water. It enters the food supply through plants, and small amounts are present in grains, vegetables, and drinking water, though modern agricultural and water treatment practices mean most people are now exposed to far less than previous generations were.

Lithium orotate is a compound that pairs lithium with orotic acid. The orotic acid functions as a carrier, improving how lithium crosses cell membranes, including the blood-brain barrier. This enhanced bioavailability means smaller doses can achieve optimal tissue concentrations, which is why the orotate form is preferred for nutritional use.

A standard lithium orotate supplement delivers approximately 5 milligrams of elemental lithium per capsule. For context, pharmaceutical lithium carbonate is prescribed at 600 to 1,800 milligrams per day, doses high enough to require regular serum monitoring because the margin between therapeutic and toxic blood levels is narrow.

At 5 milligrams of elemental lithium, you are not approaching that range. This is not a smaller version of the drug; it is a fundamentally different substance.

Think of the analogy with iron. No one hears the term “iron infusion” and assumes it is the same dose as an iron-rich meal. The molecule is similar; the dose and context are completely different. The same logic applies here.

The regulatory classification in some countries → including Canada and Australia, where all lithium regardless of dose is categorised as a drug, does not make sense.

The Water Evidence: A Trace Mineral We May Actually Need

One of the most compelling arguments for lithium as a genuine nutritional requirement comes not from supplement research but from population-level epidemiology.

Researchers have compared regions with naturally higher versus lower lithium concentrations in drinking water, and the pattern that emerges is consistent across dozens of studies spanning multiple countries and populations.

A 2021 systematic review and meta-analysis by Eyre-Watt and colleagues, covering 2,678 regions and 113 million people found that higher lithium in drinking water was associated with significantly lower suicide rates and fewer psychiatric hospital admissions.

This is not a drug effect. It is what happens when a mineral is present in an environment versus absent from it. The parallel with iodine is instructive: in areas where soil and water are iodine-deficient, thyroid problems increase markedly. We do not classify iodine as a drug because of this association.

We classify it as a nutrient that the body requires in small amounts. Researchers, including Szklarska and Rzymski in a 2019 review in Biological Trace Element Research, have argued that lithium may deserve the same classification.

It is also worth noting that dietary lithium intake has been declining. Modern intensive agriculture depletes soil mineral content over time, and municipal water treatment removes or dilutes naturally occurring trace elements. 

The Key Benefits Of Lithium Orotate

Mood Stabilisation and Emotional Resilience

At nutritional doses, lithium modulates dopamine and serotonin signalling. People who respond well are often not in acute crisis. They describe themselves as generally fine but flat: low-grade irritability without obvious cause, emotional reactivity that feels slightly out of proportion to circumstances, a general blunting of positive affect.

This is also a pattern seen in premenstrual dysphoric disorder (PMDD). The mood changes and irritability that track with the luteal phase often have a neurochemical component and not just a hormonal imbalance like in PMS. I have seen lithium orotate to be helpful for PMDD.

Sleep Quality

Lithium does not act as a sedative the way melatonin does. What it does is help regulate circadian rhythm at a cellular level,  it influences the expression of clock genes that govern the sleep-wake cycle. When that regulation is disrupted, sleep becomes light, fragmented, and not restorative, even when sleep duration appears adequate. 

If cortisol dysregulation has already been addressed and sleep quality remains poor, with good sleep hygiene then Lithium orotate could be something to trial.

The B12 Connection

Lithium plays a role in the cellular transport of vitamin B12, and potentially folate. Think of it this way: B12 needs a key to cross the cell membrane and perform its functions inside the cell. Lithium appears to be part of that transport mechanism.

What this means practically is that a person can have normal B12 on a serum blood test,  meaning the vitamin is circulating in the bloodstream and you can still be deficient because it is not getting into the cells where it needs to act. The bottleneck is not the nutrient itself but the transport system.

This is directly relevant to anyone who has supplemented B12 consistently, confirmed elevated serum levels on testing, and still experiences brain fog, fatigue, or mood symptoms that should theoretically improve with adequate B12. The issue may not be the B12. It may be the key that gets it through the door. 

Anxiety and Stress Resilience

Lithium helps regulate glutamate, the brain’s primary excitatory neurotransmitter. When glutamate signalling becomes excessive, which happens under chronic stress and in anxiety disorders the result is the familiar experience of being stuck in your head: rumination, hypervigilance, difficulty disengaging from worry. Lithium appears to reduce this baseline excitatory tone.

It also modulates the HPA axis, the hypothalamic-pituitary-adrenal system that governs the stress response in a way that reduces cortisol reactivity over time. This is different from taking something that produces acute calm. It is more like gradually reducing the system’s resting set-point, so it is not running hot all the time.

A Jones et al. 2022 study in the Journal of Affective Disorders found significant anxiety reduction with low-dose lithium in a six-week open-label trial, with over half of participants reaching full remission.

Neuroprotection: The Long-Term Case

This is where the evidence becomes genuinely exciting, particularly for anyone thinking about brain resilience over decades rather than just symptom management today.

Lithium inhibits an enzyme called GSK-3 beta (glycogen synthase kinase-3 beta). This enzyme is implicated in the formation of the amyloid plaques and neurofibrillary tangles that characterise Alzheimer’s disease. It also drives neuroinflammation. By inhibiting GSK-3 beta, lithium interrupts several of the processes that, over time, degrade cognitive function.

Simultaneously, lithium increases the expression of brain-derived neurotrophic factor (BDNF), which is the primary signalling molecule responsible for neuronal growth, repair, and survival.

Low BDNF is consistently associated with depression, cognitive decline, and accelerated neurodegeneration. Raising it is one of the goals of both exercise and antidepressant treatment.

Brain Research

A comprehensive 2023 review by Hamstra and colleagues in Current Neuropharmacology described these mechanisms in detail, covering GSK-3 beta inhibition, BDNF upregulation, neuroinflammation reduction, and amyloid-beta clearance at low doses.

A 2024 review by Manchia et al. in the International Journal of Bipolar Disorders summarised the dose-response evidence and discussed how lithium’s neuroprotective effects appear to extend well below conventionally therapeutic serum concentrations.

A notable 2013 microdose trial (Nunes et al.) found that patients with Alzheimer’s disease who received 300 micrograms of lithium per day, far below typical lithium orotate doses remained cognitively stable over 15 months while the placebo group continued to decline, with final MMSE scores of roughly 25 in the lithium group versus 18 in the placebo group. 

And in 2025, a paper published in Nature (Aron et al.) reported that people with mild cognitive impairment and Alzheimer’s disease had markedly lower lithium concentrations in brain tissue raising the possibility that lithium deficiency itself may be a contributing factor to disease onset.

If there is a family history of dementia, or early cognitive changes are already being noticed, low-dose lithium is one of the more evidence-supported nutritional tools that we currently have, and is why I take 5mg of lithium once or twice a week.

Why It Is Not Available Everywhere

In the US, lithium orotate is available over the counter as a dietary supplement. In Canada and Australia, all lithium regardless of dose is classified as a drug.

The regulatory logic is difficult to follow. There is no meaningful safety concern at 5 milligrams of elemental lithium that justifies placing it in the same category as a 900-milligram psychiatric medication.

It is a bit like classifying chamomile tea as a sedative drug because it contains compounds that promote relaxation. The dose makes all the difference, and that distinction is simply not being made.

For people in Canada and Australia who want access to lithium orotate, it is available from US-based supplement companies. Seeking Health is one reputable option. That decision is a personal one to make with full awareness of the regulatory context.

Who Should Not Take This

This section is important because not everyone should take lithium orotate.

Anyone currently on prescription lithium should not add lithium orotate without direct medical supervision. The monitoring requirements for pharmaceutical lithium exist for a reason, and adding an orotate supplement changes the picture in ways that need professional oversight.

People with kidney disease should approach this cautiously or avoid it entirely. Lithium is cleared renally, and impaired clearance means accumulation,  even at low doses. 

People taking NSAIDs (such as ibuprofen or naproxen) regularly, ACE inhibitors, or diuretics need to be particularly careful. These medications impair renal clearance of lithium and even a small dose can build to higher levels than intended.

This requires a conversation with a practitioner who understands the interaction before proceeding, it does not mean you can’t take it but you may need less.

People with pre-existing thyroid conditions should monitor their thyroid function. High-dose lithium is well documented to affect thyroid activity. The risk at orotate doses is considerably lower, but it is not zero, particularly in someone whose thyroid is already compromised.

Finally, anyone who tries lithium orotate and notices increased fatigue, emotional flatness, or mood changes in the wrong direction should stop. Some people simply do not respond well, and there is no benefit in continuing something that is making things worse.

Dosage and Practical Guidance

Most lithium orotate supplements deliver 5 milligrams of elemental lithium per capsule. This is the standard starting point.

Some people do well with 5 milligrams daily. Others find that 5 milligrams two or three times per week is sufficient, particularly when the goal is long-term mood stability or neuroprotection rather than addressing acute symptoms. More is not automatically better here. Start with a single capsule, observe the response over one to two weeks, and adjust from there.

A survey of real-world lithium orotate users published in the Canadian Journal of Psychiatry in 2025 (Strawbridge et al.) found consistent reports of mood and anxiety improvement at around 10 milligrams of elemental lithium per day, which aligns with the general clinical experience.

General practitioners are unlikely to be familiar with lithium orotate as it sits outside conventional prescribing, and most medical training does not cover nutritional doses of lithium at all. Working with a practitioner who understands functional and nutritional medicine is the key to working out whether this is a good option for you and the right dose for you.

Summary

Lithium orotate is a nutritional supplement delivering trace amounts of elemental lithium, amounts comparable to what previous generations obtained from food and water, and far below the doses used in psychiatric medicine.

The case for taking it is based on population data consistently linking higher environmental lithium with better mental health outcomes, and recent research showing neuroprotective effects through GSK-3 beta inhibition and BDNF upregulation; clinical observations of benefit in mood, sleep, anxiety, and PMDD; and emerging research on lithium’s role in cellular B12 transport.

The people most likely to benefit are those experiencing low-grade mood flatness, sleep that never quite feels restorative, anxiety rooted in chronic neural overactivation, or who have a family or personal history of cognitive decline.

The contraindications are specific and important: kidney disease, prescription lithium use, and certain medication interactions require either avoidance or careful monitoring.

Frequently Asked Questions

What other nutrients or supplements work well alongside lithium orotate?

Magnesium and lithium have complementary roles in neurological function, both are involved in NMDA receptor regulation and HPA axis modulation, so ensuring adequate magnesium status is sensible if lithium orotate is being considered. 

B12 and folate are relevant given lithium’s role in their cellular transport. Omega-3 fatty acids support the neuroinflammatory context that lithium’s neuroprotective mechanisms are also working within.

Phosphatidylserine is worth considering if cortisol dysregulation is part of the picture, as it operates through a different mechanism (HPA axis suppression) that complements rather than duplicates what lithium offers.

See the related articles on magnesium, omega-3 fatty acids, and phosphatidylserine for more detail on each.

References

• Drinking water lithium and neuropsychiatric outcomes — Eyre-Watt et al., 2021
• Is lithium a micronutrient? — Szklarska & Rzymski, 2019
• Beyond its psychiatric use: low-dose lithium supplementation (neuroprotection, BDNF, GSK-3β) — Hamstra et al., 2023 | PMC full text
• Lithium and its effects: does dose matter? — Manchia et al., 2024
• Lithium and anxiety in bipolar depression (six-week low-dose trial) — Jones et al., 2022
• Lithium deficiency and the onset of Alzheimer’s disease — Aron et al., 2025
• Survey of real-world lithium orotate use — Strawbridge et al., Can J Psychiatry, 2025 (PubMed link not yet indexed at time of writing)